» Articles » PMID: 30554229

Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation

Overview
Journal Digestion
Specialty Gastroenterology
Date 2018 Dec 17
PMID 30554229
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Ulcerative colitis (UC) patients in clinical remission often experience irritable bowel syndrome (IBS)-like symptoms. The prevalence rate of UC patients meeting the definition of IBS, such as shown by the Rome criteria, is significantly higher in those without ongoing clinical activity as compared to healthy controls. Several studies have investigated residual low-grade inflammation found in colonic mucosa of quiescent UC patients and its association with development of IBS-like symptoms. In these patients, residual colonic inflammation was evaluated using endoscopy and histology findings, as well as fecal calprotectin level and shown to not be simply associated with the presence of IBS-like symptoms in UC patients in clinical remission. However, these results are limited by the low number of related investigations conducted. Additional appropriately designed studies are necessary to confirm the relationship of low-grade colonic inflammation with IBS-like symptoms associated with UC.

Citing Articles

Unveiling the efficacy of paroxetine and gabapentin in ulcerative colitis patients in remission with co-existing IBS-like symptoms: a single-blinded randomized clinical trial.

Safaei F, Shahrokh S, Naderi N, Rastegar R, Shamsi A Front Med (Lausanne). 2024; 11:1468885.

PMID: 39635600 PMC: 11614664. DOI: 10.3389/fmed.2024.1468885.


Ulcerative colitis: molecular insights and intervention therapy.

Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C Mol Biomed. 2024; 5(1):42.

PMID: 39384730 PMC: 11464740. DOI: 10.1186/s43556-024-00207-w.


Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey.

Burisch J, Hart A, Sturm A, Rudolph C, Meadows R, Jus A Inflamm Bowel Dis. 2024; 31(2):411-424.

PMID: 38848452 PMC: 11808571. DOI: 10.1093/ibd/izae119.


Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial.

Moradi S, Bagheri R, Amirian P, Zarpoosh M, Cheraghloo N, Wong A BMC Complement Med Ther. 2024; 24(1):109.

PMID: 38424572 PMC: 10905931. DOI: 10.1186/s12906-024-04400-w.


Cannabidiol and Intestinal Motility: a Systematic Review.

Story G, Briere C, McClements D, Sela D Curr Dev Nutr. 2023; 7(10):101972.

PMID: 37786751 PMC: 10541995. DOI: 10.1016/j.cdnut.2023.101972.